Clinical studies have demonstrated the close connection between variations in the FTO gene and hip fracture risk [191], confirming that FTO SNPs are correlated with variations in bone mineral density (BMD), potentially establishing them as new biomarkers for osteoporosis [192]. The gene discussed is FTO; the disease is osteoporosis.